This is a pilot trial testing the safety and feasibility of using PSMA-PET and mpMRI to optimize radiotherapy targets for patients with low-risk or intermediate-risk prostate cancer.
Thank you for your interest, but this study is recruiting by invitation only.
North Carolina (Statewide)
Michael Repka
Radiation Oncology - Chapel Hill
Clinical or Medical
Interventional
Cancer (Prostate)
19-1123